Objectives/Hypothesis: To assess clinical success and safety of endoscopic pharyngoesophageal dilation after chemoradiation or radiation for head and neck cancer and to identify variables associated with dilation failure.
INTRODUCTION
Head and neck cancer (HNC) is the fifth most common cancer worldwide and accounts for approximately 3% of all malignancies in the United States.
1,2 More than 90% of HNCs are squamous cell cancers. 3 Survival for patients with advanced-stage disease undergoing adjuvant or primary chemoradiation (CRT) has increased [4] [5] [6] [7] [8] but is sometimes associated with late toxicities that may diminish the patient's quality of life. 9 Dysphagia, caused by partial or complete esophageal stenosis, is a particularly debilitating treatment consequence. The close proximity of mucous membranes in the pharyngoesophageal area make this site especially susceptible for stenosis formation. 10 The healing process after radiation damage, involving fibrosis and scar tissue formation, can result in a concentric stricture. 11 A recently published meta-analysis describes the risk for pharyngoesophageal stenosis in HNC with conventional radiation treatment (RT) to be 5.7% and notes a more than threefold increase, to 16 .7%, with intensitymodulated RT in combination with chemotherapy. 12, 13 Most patients have partial stenoses that are amenable to standard antegrade esophageal dilation techniques with low rates of esophageal perforation. Dilation of complete esophageal stenosis is more technically challenging but can be successfully achieved through a combined antegrade and retrograde endoscopic dilation (CARD) technique. 14 The aim of this retrospective study was to assess success rates and safety of endoscopic esophageal dilation in HNC patients who have undergone CRT or RT.
We also wanted to identify variables associated with poor outcome after esophageal dilation.
MATERIALS AND METHODS
A retrospective analysis was performed on HNC patients that underwent antegrade or CARD pharyngoesophageal dilation between January 2000 and December 2008. Patients were identified by searching the database for all patients that underwent esophageal dilation after CRT or RT for HNC at the DanaFarber Cancer Institute and Brigham and Women's Hospital. Treatment regimens included primary concurrent or sequential CRT/RT and primary surgery with adjuvant CRT/RT. The study population consisted of patients with primary tumors in the oral cavity, oropharynx, hypopharynx, larynx, nasopharynx, and unknown primaries. All patients had a minimum follow-up of 12 months after the initial dilation. Patients with thyroid tumors or primaries outside the head and neck area, such as lung cancers or esophageal cancers, or with recurrence in the stenotic segment were excluded. The protocol was approved by the institutional review board.
Pharyngoesophageal Strictures
Before endoscopic esophageal dilation, dysphagia assessment with a video swallowing study was undertaken in most patients. Stricture location was categorized as cricopharyngeal, esophageal, or pharyngeal. Stricture severity was endoscopically gauged by the size of the stenotic segment: complete stenosis; partial stenosis 5 mm; and partial stenosis >5 mm.
Dysphagia Assessment Pre-and Postdilation
Dysphagia assessment included diet consistency and gastrostomy tube (GT) status predilation and 1, 3, 6, and 12 months postdilation. Before RT or CRT, all patients were recommended to undergo GT placement. Diet was described in five categories: nothing by mouth, liquid, pureed, soft, or regular diet. As a measurement for success of dilation, the Diet/GT Scale was utilized. 15 The five-level scoring system combines GT status and diet: score 1, GT present and nothing by mouth; score 2, GT present and liquid/pureed diet; score 3, GT present and soft/regular diet; score 4, no GT and liquid/pureed diet; score 5, no GT and soft/regular diet.
Endoscopic Dilation Procedures
Patients with complete pharyngoesophageal stenosis underwent CARD via a technique previously described by Goguen et al. 14 Patients with partial stenosis, whereby a guidewire could be passed through the stenotic segment, underwent antegrade dilation using a guidewire and progressively larger dilators (Savary-Gilliard guidewire; Cook Endoscopy, WintonSalem, NC). Alternatively, a smaller subset of patients with partial stenosis underwent antegrade dilation without a guidewire. Dilation technique was at the discretion of the surgeon. Repeat dilations were performed based on the patient's dysphagia symptoms. Shortly after dilation, patients followed up with their swallow therapist to establish a safe oral diet and to continue swallow therapy.
Statistics
Univariate and multivariate logistic regression analyses were performed to evaluate possible variables associated with dilation failure and with perforation. Factors included in the analyses were clinical and treatment factors, including age, sex, size of stenosis, T and N stage, type of treatment, predilation diet, complications, time of dilation, and number of dilations. Postdilation Diet/GT score of 1, 2, or 3 was considered a poor outcome and defined as dilation failure. The Wald v 2 test from the logistic regression model was used to test for statistical significance. Variables with P <.25 were considered for model building of the multivariate analyses. A two-sided P <.05 was considered statistically significant. Time from dilation to GT removal was analyzed using the method of Kaplan and Meier. SAS, version 9.2 (SAS Institute, Cary, NC) was used for all analyses
RESULTS

Patient Characteristics
One hundred and eleven patients met inclusion criteria for this study ( Table I) .
Evaluation of Swallowing Function
The median time from completion of CRT/RT to first dilation was 5.9 months (range, 2.3-99.6 months). The majority of patients, 95 of 111 (86%), underwent videofluoroscopy before first dilation, which demonstrated partial or complete stenosis in 91% (86 of 95) patients. Videofluoroscopy showed further swallowing impairment, mostly oropharyngeal dysphagia, in 72% of those patients. At the time of dilation, 92 of 111 (83%) patients were GT dependent, and 19 of 111 (17%) patients had their GTs removed. Patients' swallowing function was further evaluated according to dietary intake predilation (Table II) . A total of 33% (37 of 111 patients) were unable to take any oral diet, and 21% (25 of 111) took an oral diet with soft or regular food.
Pharyngoesophageal Stenosis
Stenoses were found in most patients at the cricopharyngeal or upper cervical esophageal regions (109 of 111 [98%]). Only two patients had stenosis in other areas of the pharynx including base of tongue and hypopharynx. Three patients had longer stenosis extending over multiple regions from hypopharynx to cervical esophagus. Partial stenosis with lumen >5 mm was found in 61% of patients, 5-mm stenosis in 18%, and complete stenosis in 21% of patients at time of first dilation. A total of 271 dilations were performed. Repeat dilations were needed in 65 of 111 (59%) patients (Table III) . On average, each patient underwent 2.4 dilations, and the median number of dilations per patient was 2.
Dilation Techniques
Three different dilation techniques were recorded during the observation period (Table III) . Dilation over a guidewire was the most common technique in patients with partial stenosis. Some patients (11 patients) with minor partial stenosis underwent dilations without a guidewire (21 dilations). The size of partial stenosis ranged from 3 to 14 mm before the first dilation, and antegrade dilation achieved a lumen between 12 and 20 mm in these patients. Twenty-two patients with complete esophageal stenosis underwent CARD. Successful CARD dilations, in patients with complete stenosis, achieved a lumen between 10 and 20 mm.
Success of Endoscopic Esophageal Dilation
Success of the endoscopic dilation was assessed by the following measures: the ability to achieve intraoperative pharyngoesophageal patency and dilation of the stenotic segment, oral diet, GT dependence and Diet/GT score at 1, 3, 6, and 12 months postdilation (Table II) . In 106 of 111 (95%) patients, the initial dilation accomplished intraoperative patency and the stenotic segment was dilated. Median Diet/GT score predilation was 2 (GT dependent with liquid/pureed diet), and patients showed improved median Diet/GT score of 3 (GT dependent with soft/regular diet) at 1 month and of 5 (GT independent with soft/regular diet) at 12 months after dilation (Fig.  1) . One month after dilation, the biggest improvement in swallowing function was observed in patients with initial Diet/GT score of 1 and 2 whose Diet/GT scores increased in 70% (26 of 37) and 65% (28 of 43), respectively (Fig. 2) . One year after dilation, 104 of 111 (94%) achieved an oral diet, and the GT was removed in 87 of 111 (78%) patients (Fig. 3) .
Additional swallow recovery was noted after the 1 year postdilation observation period. Further assessment at 24 months revealed that 98 of 111 patients (88%) had their GTs removed.
Patients With Persistently Poor Swallowing Function
Seven of 111 (6%) patients remained GT dependent and nothing by mouth at 1 year postdilation. This group had diverse patient characteristics (Table IV) : four of seven patients had complete stenosis requiring CARD, and in one of four, intraoperative pharyngoesophageal patency was not attained. Six of seven patients had between two and eight repeat dilations. Two patients were able to become GT independent at a later time point between 18 and 24 months.
Complications After Endoscopic Esophageal Dilation
There were no deaths associated with the dilation procedures. The complication rate per dilation procedure was 9% (25 of 271) and included: eight of 208 (4%) in antegrade guidewire dilations; one of 21 (5%) in dilations without guidewire; and 16 of 42 (38%) CARD (Table V) . Complications requiring significant intervention were four of 271 (1.4%).
Perforation was the most common complication encountered in 11 of 271(4%) dilations, whereby seven of 42 (16%) perforations occurred in CARD and four of 208 (2%) perforations in antegrade guidewire dilations. These perforations were mostly microperforations (7 of 271 [2.5%]), and resulted in pneumothorax, pneumomediastinum, or subcutaneous emphysema in the neck appreciated on postprocedure chest radiograph. Patients were treated with intravenous antibiotics, observed in the hospital, and followed with serial chest radiographs. No further intervention was required for those patients with microperforations.
A perforation requiring more intervention occurred in four patients. Two patients, who underwent guidewire dilation, developed pharyngocutaneous fistulas that resolved with intravenous antibiotics and wound packing. Chest tube placement and temporary pharyngeal stent for treatment of pneumothorax and pharyngeal tear were necessary in one CARD patient. In addition, one patient developed an epidural abscess after antegrade guidewire dilation that required spinal canal decompression This patient recovered completely Among patients receiving CARD, GT site complications were found in eight of 42 (19%) dilations. These included pneumoperitoneum and leakage around the GT site. Almost all of those patients were treated conservatively with observation and serial chest or abdominal radiographs with successful resolution of pneumoperitoneum. Exchange of GT in the operating room was only necessary for one patient.
Although the vast majority of complications did not require a return to the operating room, an increased length of hospital stay was seen in 18 of 25 (72%) of the procedures with complications. Assessment of diet and GT status after a complicated dilation procedure showed that 17 of 22 patients had their GT removed and were able to eat a soft or regular diet.
Analysis of Factors Affecting Successful Dilation
Univariate logistic regression analyses were performed to look for associations with poor outcome after dilation (Table VI) . A low Diet/GT score, group 1-3, at 1 year after initial dilation was used to define patients with a poor dilation outcome. Results indicated that an increasing number of dilations during the first year were strongly associated with a poor outcome. Patients with higher T stage had a tendency to perform worse, as well as patients where the initial dilation procedure was performed 6 months after the end of CRT, but both factors did not reach statistical significance. The extent of stenosis, considering complete stenosis involving CARD dilation, versus partial stenosis, was not associated with worse outcome. In the multivariate model, after controlling for sex, T stage, time of dilation, predilation diet, and complete versus partial stenosis, the number of dilations remained statistically significant (P 5.04; OR 5 1.5; 95% CI, 1.02-2.09).
DISCUSSION
Pharyngoesophageal strictures are a frequent problem encountered in patients with HNC treated with combined modality therapy. Partial stenosis develops in 9% to 21% 11, 16, 17 and complete stenosis in 0.8% to 4%. 10, 13 Endoscopic therapy, with antegrade or anteretrograde esophageal dilations, is an established treatment to alleviate pharyngeal or esophageal stenosis post HNC treatment. However, only a few studies have looked at management and outcome of endoscopic dilations in this patient group. 14, 18, 19 The purpose of this study was to assess success and safety of dilation procedures in HNC patients after treatment. We identified 111 patients who underwent 271 endoscopic esophageal dilations following HNC treatment, making this one of the largest and most detailed studies in the literature.
Our results show that technical success, as seen by achieving intraoperative esophageal patency and dilating the stenosis, was achieved in 95%. Similar results were found by Dhir et al., 19 who attained esophageal patency in 20 of 21 patients dilated with antegrade guidewire technique. Another case series by Ahlawat and Al-Kawas 20 reported technical success in 80% of patients, also treated with antegrade guidewire dilations.
The measures for functional success of dilations in our study were GT status, diet, and the Diet/GT score. Other dysphagia scales used in HNC patients are the Swallowing Performance Status Scale (SPSS) 21 or the functional oral intake scale (FOIS). 22 The SPSS requires a videofluoroscopy for assessment that was not available for all of our patients postdilation. The FOIS was validated in stroke patients and only recently applied to HNC patients by Kotz et al. 23 in a prospective, randomized trial. In the retrospective setting of this study we chose the Diet/GT score because it combines the two objective criteria, diet and GT status, and was previously applied to HNC patients successfully from our group. 15 Small patient numbers in other case series and diverse approaches for reporting dilation success make a comprehensive comparison of our results challenging. An improvement from median predilation Diet GT score of 2 to median score of 3 was observed 1 month after dilation. Successful removal of GT was found in 78% after 1 year and in 88% after 2 years. Dhir et al. 19 used a dysphagia scale and reported adequate dysphagia relief in 75% patients. These patients had either no dysphagia or occasional dysphagia to solids 4 to 36 weeks postprocedure. The same dysphagia scale was used by Ahlawat and AlKawas, 20 reporting 84% adequate dysphagia relief. GT status was not reported in these studies. Other smaller case series on CARD dilations stated improvement in oral intake in six of seven patients. 24 The majority of our patients achieved intraoperative esophageal patency, yet a significant number, 49% (54 of 111), required repeat dilations. This is consistent with other clinical studies demonstrating the need for multiple dilations. 18, 20, 24, 25 Case series reports, using antegrade dilation technique, identified the need for multiple dilations in 74%, 26 58%, 20 and 33%. 19 For patients undergoing an initial CARD dilation, Fowlkes et al. 18 reported an average need of seven anterograde dilations following the initial CARD procedure. Comparing this data to our case series, repeated antegrade dilations were required in most CARD patients with an average of three dilations following CARD. Beyond the technical success, many other factors influence swallowing postdilation. As seen on predilation video swallow, 72% of our patients also had oropharyngeal phase swallow dysfunction. This is the result of tissue edema, deformed anatomy, and immobility of the larynx and cricoid owing to postradiation changes. 20, 27, 28 All of our study patients participated in post-CRT swallow therapy as a crucial part of their treatment. Specific swallowing exercises directed toward structures impaired during and after CRT have been shown to improve swallowing outcome.
23,29-31 Therefore, we believe not all swallowing improvement noted in the observation period, especially at long-term follow-up, can be attributed to the dilation procedures. Rather, multiple factors contribute to swallowing recovery, including dilation procedures, swallow therapy, and postradiation tissue recovery over time.
Our overall complication rate was low at 9% for a total of 271 dilations, demonstrating that pharyngoesophageal dilations are relatively safe. The most common complications were perforations (4%), which occurred usually as microperforations and resolved spontaneously. A case series by Hernandez et al. 32 reported a similar rate of 3.9% for anterograde dilations. Higher perforation rates between 17% and 25% were noticed for CARD dilations. 27, 33 Unique to CARD were GT site complications observed in 19% of our CARD procedures, which were managed successfully with observation in the majority of cases. In other smaller case series, GT complications were seen in 12%. 18, 33 Dilation of the GT site to permit retrograde passage of flexible gastroscope is the main factor contributing to these complications. In general, our large patient series revealed mainly minor complications, but there remains a risk for serious complications, particularly related to pharyngoesophageal perforations, and diligent postoperative care is needed.
CONCLUSION
Our study shows that anterograde and combined anteretrograde dilation techniques are not only safe but also a very successful treatment method for HNC patients with pharyngoesophageal strictures after CRT and RT treatment. The number of dilations within the first year was associated with persistent dysphagia and a risk for perforation. The outcome for these models is having a GT/Diet score of 1, 2, or 3.
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